ATE165603T1 - Methandiphosphonsäurederivat, herstellung davon und verwendung davon als arzneimittel - Google Patents
Methandiphosphonsäurederivat, herstellung davon und verwendung davon als arzneimittelInfo
- Publication number
- ATE165603T1 ATE165603T1 AT92918702T AT92918702T ATE165603T1 AT E165603 T1 ATE165603 T1 AT E165603T1 AT 92918702 T AT92918702 T AT 92918702T AT 92918702 T AT92918702 T AT 92918702T AT E165603 T1 ATE165603 T1 AT E165603T1
- Authority
- AT
- Austria
- Prior art keywords
- alkyl
- acid derivative
- methandiphosphoic
- production
- medicinal product
- Prior art date
Links
- 239000002253 acid Substances 0.000 title 1
- 229940126601 medicinal product Drugs 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 230000005764 inhibitory process Effects 0.000 abstract 2
- 208000023275 Autoimmune disease Diseases 0.000 abstract 1
- 208000006386 Bone Resorption Diseases 0.000 abstract 1
- 208000018083 Bone metabolism disease Diseases 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 108010002352 Interleukin-1 Proteins 0.000 abstract 1
- 208000001132 Osteoporosis Diseases 0.000 abstract 1
- 101100073357 Streptomyces halstedii sch2 gene Chemical class 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 230000003078 antioxidant effect Effects 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 230000024279 bone resorption Effects 0.000 abstract 1
- 150000001768 cations Chemical class 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000005842 heteroatom Chemical group 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- MBKDYNNUVRNNRF-UHFFFAOYSA-N medronic acid Chemical class OP(O)(=O)CP(O)(O)=O MBKDYNNUVRNNRF-UHFFFAOYSA-N 0.000 abstract 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 150000002829 nitrogen Chemical class 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 239000011593 sulfur Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
- C07F9/3839—Polyphosphonic acids
- C07F9/386—Polyphosphonic acids containing hydroxy substituents in the hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
- C07F9/3839—Polyphosphonic acids
- C07F9/3865—Polyphosphonic acids containing sulfur substituents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4025—Esters of poly(thio)phosphonic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4025—Esters of poly(thio)phosphonic acids
- C07F9/404—Esters of poly(thio)phosphonic acids containing hydroxy substituents in the hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4025—Esters of poly(thio)phosphonic acids
- C07F9/405—Esters of poly(thio)phosphonic acids containing nitrogen substituent, e.g. N.....H or N-hydrocarbon group which can be substituted by halogen or nitro(so), N.....O, N.....S, N.....C(=X)- (X =O, S), N.....N, N...C(=X)...N (X =O, S)
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP22617591 | 1991-09-05 | ||
| JP17980292 | 1992-07-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE165603T1 true ATE165603T1 (de) | 1998-05-15 |
Family
ID=26499539
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT92918702T ATE165603T1 (de) | 1991-09-05 | 1992-09-07 | Methandiphosphonsäurederivat, herstellung davon und verwendung davon als arzneimittel |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US5527940A (de) |
| EP (1) | EP0594857B1 (de) |
| JP (1) | JPH0826048B2 (de) |
| AT (1) | ATE165603T1 (de) |
| CA (1) | CA2095128C (de) |
| DE (1) | DE69225325T2 (de) |
| DK (1) | DK0594857T3 (de) |
| ES (1) | ES2114946T3 (de) |
| WO (1) | WO1993005052A1 (de) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69329199D1 (de) * | 1992-05-29 | 2000-09-14 | Procter & Gamble Pharma | Schwefel-enthaltende phosphonat-verbindungen zur behandlung von abnormalem calzium- und phosphat- metabolismus |
| JPH06135976A (ja) * | 1992-10-30 | 1994-05-17 | Toray Ind Inc | メタンジホスホン酸誘導体、その製造方法およびその医薬用途 |
| JP3626500B2 (ja) * | 1994-12-22 | 2005-03-09 | 東レ株式会社 | 「ビス(4−アルキルチオフェニル)ジスルフィドの製造法」 |
| EP0998934A4 (de) * | 1997-12-25 | 2005-09-14 | Toray Industries | Heilmittel gegen intramedullare krankheiten |
| DE19828450A1 (de) * | 1998-06-26 | 1999-12-30 | Hassan Jomaa | Bisphosphonsäuren und deren Derivate enthaltende Arzneimittel zur Prophylaxe und zur Behandlung von Autoimmunkrankheiten sowie von Allergien |
| EP1057488A4 (de) * | 1998-12-25 | 2003-10-22 | Toray Industries | Inhibitoren der interleukin-6 produktion |
| EP1114642B1 (de) * | 1999-07-19 | 2010-01-06 | Toray Industries, Inc. | Medikamente zur behandlung von periodontalen erkrankungen |
| EP1118328A1 (de) * | 1999-08-02 | 2001-07-25 | Toray Industries, Inc. | Einfügungsstabilisatoren für implantate |
| JP2001181191A (ja) * | 1999-12-24 | 2001-07-03 | Cci Corp | 慢性関節リウマチ疾患予防および治療剤 |
| US6548042B2 (en) | 2000-08-07 | 2003-04-15 | Arstad Erik | Bis-phosphonate compounds |
| US20060040899A1 (en) * | 2000-12-15 | 2006-02-23 | Hassan Jomaa | Medicaments containing bisphosphonic acids and derivatives thereof for preventing and treating diseases and allergies |
| WO2003094851A2 (en) * | 2002-05-11 | 2003-11-20 | Ilex Products, Inc. | 1,1- and 1,2-bisphosphonates as apoliprotein e modulators |
| JP5655179B2 (ja) * | 2008-09-03 | 2015-01-21 | 国立大学法人東北大学 | [4−(メチルチオ)フェニルチオ]メタンビスホスホン酸又は薬学的に許容され得るその塩を有効成分とする骨形成促進剤 |
| KR102116528B1 (ko) * | 2015-09-09 | 2020-05-28 | 칭화 유니버시티 | 고-효율 백신 아쥬반트로서 메발로네이트 경로 억제제 |
| JP2024169831A (ja) * | 2023-05-26 | 2024-12-06 | 公立大学法人福島県立医科大学 | 抗酸化剤 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3609075A (en) * | 1968-06-25 | 1971-09-28 | Procter & Gamble | Cleaning and softening detergent compositions |
| EP0085321B1 (de) * | 1982-01-27 | 1986-08-27 | Schering Aktiengesellschaft | Diphosphonsäure-Derivate und diese enthaltende pharmazeutische Präparate |
| FR2531088B1 (fr) * | 1982-07-29 | 1987-08-28 | Sanofi Sa | Produits anti-inflammatoires derives de l'acide methylenediphosphonique et leur procede de preparation |
| FR2558837B1 (fr) * | 1984-01-26 | 1986-06-27 | Sanofi Sa | Derives de l'acide methylenediphosphonique, procede d'obtention et medicaments antirhumatismaux les contenant |
| US4902679A (en) * | 1985-12-13 | 1990-02-20 | Norwich Eaton Pharmaceuticals, Inc. | Methods of treating diseases with certain geminal diphosphonates |
| EP0243173B1 (de) * | 1986-04-24 | 1991-06-26 | Fujisawa Pharmaceutical Co., Ltd. | Diphosphonsäure-Verbindungen, Verfahren zu deren Herstellung und sie enthaltende Arzneimittel |
| CH675422A5 (de) * | 1988-03-31 | 1990-09-28 | Symphar Sa | |
| MX21452A (es) * | 1989-07-07 | 1994-01-31 | Ciba Geigy Ag | Preparaciones farmaceuticas que se administran en forma topica. |
| JPH0377894A (ja) * | 1989-08-18 | 1991-04-03 | Toray Ind Inc | メチレンジホスホン酸化合物 |
| EP0416689B1 (de) * | 1989-09-06 | 1995-11-29 | Merck & Co. Inc. | Acyloxymethylester der Bisphonsäuren als Knochenresorptions-Inhibitoren |
| US5157027A (en) * | 1991-05-13 | 1992-10-20 | E. R. Squibb & Sons, Inc. | Bisphosphonate squalene synthetase inhibitors and method |
| US5256808A (en) * | 1992-12-04 | 1993-10-26 | The University Of Tennessee Research Corp. | Synthesis of tetraalkyl vinylidene diphosphonate monomer |
-
1992
- 1992-09-07 AT AT92918702T patent/ATE165603T1/de not_active IP Right Cessation
- 1992-09-07 ES ES92918702T patent/ES2114946T3/es not_active Expired - Lifetime
- 1992-09-07 WO PCT/JP1992/001140 patent/WO1993005052A1/ja not_active Ceased
- 1992-09-07 JP JP5504234A patent/JPH0826048B2/ja not_active Expired - Lifetime
- 1992-09-07 DK DK92918702T patent/DK0594857T3/da active
- 1992-09-07 EP EP92918702A patent/EP0594857B1/de not_active Expired - Lifetime
- 1992-09-07 CA CA002095128A patent/CA2095128C/en not_active Expired - Fee Related
- 1992-09-07 DE DE69225325T patent/DE69225325T2/de not_active Expired - Lifetime
-
1994
- 1994-11-17 US US08/340,819 patent/US5527940A/en not_active Expired - Lifetime
-
1996
- 1996-03-15 US US08/617,937 patent/US5683992A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JPH06500489A (ja) | 1994-01-20 |
| JPH0826048B2 (ja) | 1996-03-13 |
| WO1993005052A1 (en) | 1993-03-18 |
| EP0594857A4 (en) | 1994-05-18 |
| US5527940A (en) | 1996-06-18 |
| EP0594857B1 (de) | 1998-04-29 |
| DE69225325D1 (de) | 1998-06-04 |
| EP0594857A1 (de) | 1994-05-04 |
| US5683992A (en) | 1997-11-04 |
| ES2114946T3 (es) | 1998-06-16 |
| DE69225325T2 (de) | 1998-08-27 |
| CA2095128C (en) | 1998-01-06 |
| CA2095128A1 (en) | 1993-03-06 |
| DK0594857T3 (da) | 1998-10-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69225325D1 (de) | Methandiphosphonsäurederivat, herstellung davon und verwendung davon als arzneimittel | |
| HU913436D0 (en) | Process for the production of amino-cumarane-derivatives and medical preparations containing them | |
| HU911986D0 (en) | Process for the production of cyclical amido-derivatives and the medical preparations containing them | |
| IL91474A0 (en) | Spiro compounds and their production | |
| FI932445A0 (fi) | Farmaceutiska foereningar | |
| ATE26212T1 (de) | Verwendung von amino-phenylessigs ure-derivaten zur herstellung eines immunomodulatoren arzneimittels. | |
| FI935944A0 (fi) | Pyratsolopyrimidin- samt pyrimidinylbisfosfonestrar som anti- inflammatorer | |
| HUT45984A (en) | Process for production of quinoline-derivatives and of their medically acceptable acid-additioned salts | |
| IL97249A0 (en) | Condensed thiazole compounds,their production and use | |
| IL106218A (en) | Pharmaceutical compositions containing a spiro (1,3-oxathiolane-5,3') quinuclidine derivative for curing sjoegren syndrome disease | |
| HUT59921A (en) | Process for producing hetero-aroyl derivatives of monocyclic betalactame derivatives and pharmaceutical compositions containing them | |
| HU912786D0 (en) | Process for producing 4-substituted-dihydro-pyrido(4,3-d) pyrimidine derivatives as well as pharmaceutical preparatives containing said compounds | |
| HUT66022A (en) | Vitamin d3 analogs and pharmaceutical compositions containing them and process for production thereof | |
| HUT49283A (en) | Process for production of medical compositions applicable for treatment of peptical ulcer | |
| HU9400908D0 (en) | Pharmaceutical compositions for treatng skin disorders | |
| NO173991C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,2,5-ditiazocin-derivater | |
| DE69403242D1 (de) | Cyathane Derivate und diese enthaltende Nervenwachstumsfaktor Produktion Stimulatoren und antimikrobielle Mittel | |
| HUT59930A (en) | Process for producing bis-phosphonic acid derivatives and pharmaceutical compositions containing them as active component | |
| HU912489D0 (en) | Process for producing 6-(substituted amino-propionyl)-forscholine derivatives | |
| NO162859C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive oksadiazolylimidazobenzodiazepinforbindelser. | |
| DE69401163D1 (de) | Umwandlungsverfahren von Lorabef Dihydrate in Loracarbef Monohydrate | |
| ATE136217T1 (de) | Verwendung von imino-derivaten von etianaldehyd zur herstellung eines arzneimittels zur behandlung des bluthochdrucks | |
| EP0309261A3 (en) | Butenoic acid amides, their salts, pharmaceutical compositions containing them and process for preparing same | |
| EP0623608A4 (de) | Benzopyran-derivate, deren herstellung sowie diese als aktive bestandteile enthaltende arzneimittel. | |
| EP0627438A4 (de) | Methandiphosphonsäure-derivat, verfahren zu ihrer herstellung und pharmazeutische verwendung davon. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |